GSTM1 and diabetic kidney disease: A prospective observational study performed on 40 patients with DKD found that 1 month after bevacizumab injection, diastolic blood pressure and Hb level might be increased in patients, but deterioration of renal function and increase of proteinuria was not observed (Bagheri et al., 2018).